CompletedNCT05555784

Evaluation of Impact of Disease and Visual Disability on Quality of Life and Loss of Independence of Patients Living in France With Leber's Hereditary Optic Neuropathy (LHON) Through Qualitative and Quantitative Data Collection

Studying Hereditary optic neuropathy

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Argo Sante
Principal Investigator
Marieke Podevin, PhD
Argo Sante
Enrollment
12 enrolled
Eligibility
20-60 years · All sexes
Timeline
2022 – 2023

Study locations (1)

Collaborators

GenSight Biologics

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05555784 on ClinicalTrials.gov

Other trials for Hereditary optic neuropathy

Additional recruiting or active studies for the same condition.

See all trials for Hereditary optic neuropathy →

← Back to all trials